DeepHealth and Incepto Announce Strategic Partnership To Expand Access To AI-Powered Medical Imaging
The partnership will enable healthcare providers in Europe to access DeepHealth technology via Incepto, addressing a broader range of operational and clinical challenges.
DeepHealth, a wholly owned subsidiary of RadNet, Inc., will pilot the Incepto offering across RadNet’s 366+ imaging centers in the U.S.
DeepHealth is a leading provider of AI-powered radiology informatics for real-world clinical settings with a focus on large-scale cancer screening programs.
Incepto is Europe's leading platform for artificial intelligence solutions applied to medical imaging, offering a curated portfolio of proprietary and best-of-breed third-party clinical solutions.
Vienna, Austria, Feb. 28, 2024 – Today, DeepHealth, one of the leading providers of radiology informatics and AI solutions, and Incepto, Europe's leading platform for artificial intelligence (AI) solutions applied to medical imaging, announced they are partnering to deliver expanded access to DeepHealth clinical AI and radiology informatics software. The announcement took place at the European Congress of Radiology (ECR 2024) in Vienna, Austria.
Sham Sokka, Chief Operating and Technology Officer, DeepHealth, said: “AI is rewriting the rules on what we can do with imaging technology in healthcare. DeepHealth’s radiology informatics technology, being introduced as DeepHealth OS, integrates AI into all aspects of radiology, from patient engagement to imaging and diagnosis to follow-ups. It aims to empower users across the care continuum with personalized workflows to deliver better care.”
Radiologists across Europe will be able to access DeepHealth OS, a cloud-native operating system that orchestrates clinical and operational workflows, and AI technologies, through Incepto. Incepto-curated AI solutions will be deeply integrated into the upcoming DeepHealth OS. The aim is to provide access to a wider AI-powered portfolio with integrated AI clinical solutions and workflow tools to address multiple challenges faced by radiologists and staff.
“The alliance between Incepto and DeepHealth represents a unique synergy that harnesses the combined expertise and resources of both organizations to address the most pressing challenges in radiology,” said Antoine Jomier, co-founder and CEO at Incepto. “This strategic partnership aims at delivering faster the transformative impact in healthcare by joining forces in Europe and the United States. On the technical side, this will mean that DeepHealth will leverage Incepto’s AI orchestration platform as part of the DeepHealth OS offering and will integrate the Incepto-curated portfolio of AI solutions to extend their AI solutions to healthcare providers. On the commercial side, DeepHealth will pilot the Incepto offering within the 366+ outpatient imaging centers in the United States operated by DeepHealth’s parent RadNet, Inc. (NASDAQ: RDNT), and other countries where DeepHealth has an active presence.”
Incepto’s AI orchestration platform is a system intended to coordinate and manage the integration, workflow and optimization of diverse artificial intelligence component within
DeepHealth, enhancing efficiency and scalability of radiology services across the care continuum.
Sham Sokka said: “It’s important to us that clinics across the world can benefit from these tools. Incepto will give more radiology teams across Europe access to our technology, including our lung cancer AI which is currently being used in over 90% of screening sites in the UK’s targeted lung cancer screening pilot.”
This partnership builds on DeepHealth’s current portfolio of eRAD Radiology Information and Image Management Systems, Aidence lung AI and Quantib prostate AI, which are now rebranded as Saige Lung and Prostate, and unified through DeepHealth OS, the integrated radiology informatics platform.
DeepHealth technology is already used in over 300 radiology departments and imaging centers across the world. Over 15 million exams each year are performed using DeepHealth solutions with more than two million AI-informed clinical decisions.
About DeepHealth
DeepHealth, a wholly owned subsidiary of RadNet, Inc. (NASDAQ: RDNT), provides AI-powered radiology and health informatics to empower breakthroughs in care delivery. The portfolio of solutions builds on eRAD Radiology Information and Image Management Systems, Aidence lung AI and Quantib prostate AI, which are now rebranded as Saige Lung and Prostate, and unified through DeepHealth OS, which is a cloud-native operating system that orchestrates all clinical and operational data to drive value across the enterprise. DeepHealth’s integrated portfolio aims to address challenges across the entire radiology value chain from referral management, scheduling and patient engagement to technologist workflow and interpretation, and leverages advanced AI to increase operational efficiency, clinical confidence and patient outcomes. https://deephealth.com/
About Incepto Medical
Founded in 2018, Incepto is Europe's leading platform for artificial intelligence solutions applied to medical imaging. With a presence in 300 clinics and the capacity to process over 300,000 radiological exams monthly, Incepto collaborates with medical professionals to implement effective AI solutions. Incepto's mission includes co-creating tailored applications, enhancing diagnostic accuracy, optimizing care pathways, and elevating patient care standards. Recognized as a French Tech France 2030 startup since June 2023, Incepto aligns with France's strategic goals for technology innovation and economic growth. The company invites healthcare stakeholders to join in redefining the future through innovative and collaborative AI solutions. https://incepto-medical.com/
Forward Looking Statements
This press release contains “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements, including statements regarding the capabilities of the DeepHealth health informatics product portfolio, artificial intelligence solutions, the DeepHealth OS and each’s impact on radiology practices and healthcare workflow, are expressions of our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, projections, and anticipated future conditions, events and trends. Forward-looking statements can generally be identified by words such as: “anticipate,”
“intend,” “plan,” “goal,” “seek,” “believe,” “project,” “estimate,” “expect,” “strategy,” “future,” “likely,” “may,” “should,” “will” and similar references to future periods.
Forward-looking statements are neither historical facts nor assurances of future performance. Because forward-looking statements relate to the future, they are inherently subject to uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Our actual results and financial condition may differ materially from those indicated in the forward-looking statements. Therefore, you should not place undue reliance on any of these forward-looking statements.
For DeepHealth media inquiries, please contact:
Naiara Martinez Cabrera
VP of Global Marketing, DeepHealth
Phone: +31 655 165 801
Email: naiara@deephealth.com
For Incepto media inquiries, please contact:
Jean-Baptiste Duval
Associate Director
Phone: +33 7 60 44 69 43
Email: jeanbaptiste.duval@grayling.com